116 related articles for article (PubMed ID: 11144971)
1. Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver.
Enosawa S; Miyashita T; Suzuki S; Li XK; Tsunoda M; Amemiya H; Yamanaka M; Hiramatsu S; Tanimura N; Omasa T; Suga K; Matsumura T
Cell Transplant; 2000; 9(5):711-5. PubMed ID: 11144971
[TBL] [Abstract][Full Text] [Related]
2. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure.
Enosawa S; Miyashita T; Fujita Y; Suzuki S; Amemiya H; Omasa T; Hiramatsu S; Suga K; Matsumura T
Cell Transplant; 2001; 10(4-5):429-33. PubMed ID: 11549067
[TBL] [Abstract][Full Text] [Related]
3. The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model.
Enosawa S; Miyashita T; Saito T; Omasa T; Matsumura T
Cell Transplant; 2006; 15(10):873-80. PubMed ID: 17299991
[TBL] [Abstract][Full Text] [Related]
4. An attempt to add biological functions by genetic engineering in order to produce high-performance bioreactor cells for hybrid artificial liver: transfection of glutamine synthetase into Chinese hamster ovary (CHO) cell.
Enosawa S; Suzuki S; Fujino M; Amemiya H; Omasa T; Urayama S; Tanimura N; Suga K
Cell Transplant; 1997; 6(5):537-40. PubMed ID: 9331509
[TBL] [Abstract][Full Text] [Related]
5. Construction and evaluation of drug-metabolizing cell line for bioartificial liver support system.
Omasa T; Kim K; Hiramatsu S; Katakura Y; Kishimoto M; Enosawa S; Ohtake H
Biotechnol Prog; 2005; 21(1):161-7. PubMed ID: 15903254
[TBL] [Abstract][Full Text] [Related]
6. The bioreactor with CYP3A4- and glutamine synthetase-introduced HepG2 cells: treatment of hepatic failure dog with diazepam overdosage.
Wang N; Tsuruoka S; Yamamoto H; Enosawa S; Omasa T; Sata N; Matsumura T; Nagai H; Fujimura A
Artif Organs; 2005 Aug; 29(8):681-4. PubMed ID: 16048486
[TBL] [Abstract][Full Text] [Related]
7. Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2.
Miyashita T; Enosawa S; Suzuki S; Tamura A; Tanaka H; Amemiya H; Matsumura T; Omasa T; Suga K; Aoki T; Koyanagi Y
Transplant Proc; 2000 Nov; 32(7):2355-8. PubMed ID: 11120198
[No Abstract] [Full Text] [Related]
8. Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase.
Tang NH; Wang XQ; Li XJ; Chen YL
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):621-7. PubMed ID: 19073408
[TBL] [Abstract][Full Text] [Related]
9. Methionine sulfoximine supplementation enhances productivity in GS-CHOK1SV cell lines through glutathione biosynthesis.
Feary M; Racher AJ; Young RJ; Smales CM
Biotechnol Prog; 2017 Jan; 33(1):17-25. PubMed ID: 27689785
[TBL] [Abstract][Full Text] [Related]
10. Stable overexpression of arginase I and ornithine transcarbamylase in HepG2 cells improves its ammonia detoxification.
Tang N; Wang Y; Wang X; Zhou L; Zhang F; Li X; Chen Y
J Cell Biochem; 2012 Feb; 113(2):518-27. PubMed ID: 21938740
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2.
Enosawa S; Miyashita T; Tanaka H; Li X; Suzuki S; Amemiya H; Omasa T; Suga K; Matsumura T
Transplant Proc; 2001; 33(1-2):1945-7. PubMed ID: 11267581
[No Abstract] [Full Text] [Related]
12. Limitations to the development of recombinant human embryonic kidney 293E cells using glutamine synthetase-mediated gene amplification: Methionine sulfoximine resistance.
Yu DY; Noh SM; Lee GM
J Biotechnol; 2016 Aug; 231():136-140. PubMed ID: 27288593
[TBL] [Abstract][Full Text] [Related]
13. Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologics.
Lin PC; Chan KF; Kiess IA; Tan J; Shahreel W; Wong SY; Song Z
MAbs; 2019 Jul; 11(5):965-976. PubMed ID: 31043114
[TBL] [Abstract][Full Text] [Related]
14. Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer.
Elmetwalli A; Nageh A; Youssef AI; Youssef M; Ahmed MAE; Noreldin AE; El-Sewedy T
Med Oncol; 2023 Dec; 41(1):38. PubMed ID: 38157146
[TBL] [Abstract][Full Text] [Related]
15. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
[TBL] [Abstract][Full Text] [Related]
16. Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter.
Fan L; Kadura I; Krebs LE; Larson JL; Bowden DM; Frye CC
J Biotechnol; 2013 Dec; 168(4):652-8. PubMed ID: 23994266
[TBL] [Abstract][Full Text] [Related]
17. Expression of glutamine synthetase and carbamoylphosphate synthetase i in a bioartificial liver: markers for the development of zonation in vitro.
Poyck PP; Hoekstra R; Vermeulen JL; van Wijk AC; Chamuleau RA; Hakvoort TB; van Gulik TM; Lamers WH
Cells Tissues Organs; 2008; 188(3):259-69. PubMed ID: 18354250
[TBL] [Abstract][Full Text] [Related]
18. Limitations to the development of humanized antibody producing Chinese hamster ovary cells using glutamine synthetase-mediated gene amplification.
Jun SC; Kim MS; Hong HJ; Lee GM
Biotechnol Prog; 2006; 22(3):770-80. PubMed ID: 16739961
[TBL] [Abstract][Full Text] [Related]
19. Newly established human liver cell line: a potential cell source for the bioartificial liver in the future.
Liu H; You S; Rong Y; Wu Y; Zhu B; Wan Z; Liu W; Mao P; Xin S
Hum Cell; 2013 Dec; 26(4):155-61. PubMed ID: 23797278
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver.
Poyck PP; van Wijk AC; van der Hoeven TV; de Waart DR; Chamuleau RA; van Gulik TM; Oude Elferink RP; Hoekstra R
J Hepatol; 2008 Feb; 48(2):266-75. PubMed ID: 18093687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
